Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Loss of S100 antigenicity in metastatic melanoma.

Aisner DL, Maker A, Rosenberg SA, Berman DM.

Hum Pathol. 2005 Sep;36(9):1016-9.

2.
3.

Marginal and joint distributions of S100, HMB-45, and Melan-A across a large series of cutaneous melanomas.

Viray H, Bradley WR, Schalper KA, Rimm DL, Gould Rothberg BE.

Arch Pathol Lab Med. 2013 Aug;137(8):1063-73. doi: 10.5858/arpa.2012-0284-OA.

4.

Kba.62 and S100 protein expression in cytologic samples of metastatic malignant melanoma.

Erdag G, Chowdhuri SR, Fetsch P, Erickson D, Hughes MS, Filie AC.

Diagn Cytopathol. 2013 Oct;41(10):847-51. doi: 10.1002/dc.22948. Epub 2013 Apr 3.

PMID:
23554410
5.

Value of the S100 protein in the study of nevus and ocular melanomas.

Garrido CM, Arra A.

Ophthalmologica. 1987;194(4):201-3.

PMID:
3627705
6.
7.

Microphthalmia transcription factor in the immunohistochemical diagnosis of metastatic melanoma: comparison with four other melanoma markers.

Miettinen M, Fernandez M, Franssila K, Gatalica Z, Lasota J, Sarlomo-Rikala M.

Am J Surg Pathol. 2001 Feb;25(2):205-11.

PMID:
11176069
8.

Primary mucosal malignant melanoma: an immunohistochemical study of 12 cases with comparison to cutaneous and metastatic melanomas.

Fitzgibbons PL, Chaurushiya PS, Nichols PW, Chandrasoma PT, Martin SE.

Hum Pathol. 1989 Mar;20(3):269-72.

PMID:
2722176
9.
10.

Concordant loss of melanoma differentiation antigens in synchronous and asynchronous melanoma metastases: implications for immunotherapy.

Trefzer U, Hofmann M, Reinke S, Guo YJ, Audring H, Spagnoli G, Sterry W.

Melanoma Res. 2006 Apr;16(2):137-45.

PMID:
16567969
11.

Metastatic melanoma presenting as an isolated breast tumor: a study of 20 cases with emphasis on several primary mimickers.

Bacchi CE, Wludarski SC, Ambaye AB, Lamovec J, Salviato T, Falconieri G.

Arch Pathol Lab Med. 2013 Jan;137(1):41-9. doi: 10.5858/arpa.2011-0552-OA.

PMID:
23276173
12.

Desmoplastic neurotropic melanoma. A clinicopathologic analysis of 28 cases.

Carlson JA, Dickersin GR, Sober AJ, Barnhill RL.

Cancer. 1995 Jan 15;75(2):478-94.

14.

Expression of melanocyte differentiation antigens and ki-67 in nodal nevi and comparison of ki-67 expression with metastatic melanoma.

Lohmann CM, Iversen K, Jungbluth AA, Berwick M, Busam KJ.

Am J Surg Pathol. 2002 Oct;26(10):1351-7.

PMID:
12360050
16.

Analysis of expression of the melanoma-associated antigens MART-1 and gp100 in metastatic melanoma cell lines and in in situ lesions.

Marincola FM, Hijazi YM, Fetsch P, Salgaller ML, Rivoltini L, Cormier J, Simonis TB, Duray PH, Herlyn M, Kawakami Y, Rosenberg SA.

J Immunother Emphasis Tumor Immunol. 1996 May;19(3):192-205.

PMID:
8811494
17.
18.

P75 nerve growth factor receptor staining is superior to S100 in identifying spindle cell and desmoplastic melanoma.

Lazova R, Tantcheva-Poor I, Sigal AC.

J Am Acad Dermatol. 2010 Nov;63(5):852-8. doi: 10.1016/j.jaad.2009.11.688.

PMID:
20950740
19.

Cultivation-dependent plasticity of melanoma phenotype.

Kodet O, Dvořánková B, Krejčí E, Szabo P, Dvořák P, Štork J, Krajsová I, Dundr P, Smetana K Jr, Lacina L.

Tumour Biol. 2013 Dec;34(6):3345-55. doi: 10.1007/s13277-013-0905-x. Epub 2013 Jun 12.

PMID:
23757003
20.

S100 immunophenotypes of uveal melanomas.

Kan-Mitchell J, Rao N, Albert DM, Van Eldik LJ, Taylor CR.

Invest Ophthalmol Vis Sci. 1990 Aug;31(8):1492-6.

PMID:
1696942

Supplemental Content

Support Center